Single-cell Spatial Analysis May Help Predict Response to Neoadjuvant Immunotherapy in Triple-negative Breast Cancer
Imaging mass cytometry was feasible in a large clinical trial of atezolizumab in combination with chemotherapy SAN ANTONIO –...
Under-recognition of Symptoms May Be Common in Patients With Breast Cancer Receiving Radiotherapy
Symptom under-recognition may be more common among younger patients and Black patients SAN ANTONIO – Among patients with breast...
First-line Ribociclib Plus Endocrine Therapy May Be More Effective Than Combination Chemotherapy in Patients With Aggressive Breast Cancer
Patients were pre- or perimenopausal with hormone receptor-positive, HER2-negative tumors SAN ANTONIO – In patients with hormone receptor-positive, HER2-negative,...
Circulating Tumor Cell Count Could Help Choose Treatment for Metastatic Breast Cancer Patients
SAN ANTONIO – Circulating tumor-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline treatment...
Breast Cancer Patients with Estrogen Receptor Mutations May Benefit From Early Switch to Fulvestrant/Palbociclib
Mutations were detected via circulating tumor DNA before disease progression in patients treated with an aromatase inhibitor/palbociclib for hormone...
Oral Paclitaxel Yielded Better Outcomes Than Intravenous Paclitaxel for Metastatic Breast Cancer Patients in Phase III Trial
SAN ANTONIO — Metastatic breast cancer patients who received an oral formulation of the chemotherapy drug paclitaxel had better...
Liquid Biopsies in SOLAR-1 Trial Predict Benefit of Alpelisib in PIK3CA-Mutant Breast Cancer
“SAN ANTONIO – Liquid biopsy-based assessment of PIK3CA mutational status served as a better indicator of progression-free survival compared...
Sexual Health Symptoms May Correlate With Poor Adherence to Adjuvant Endocrine Therapy in Black Women With Breast Cancer
Symptoms were associated with lower mental quality of life for both Black and white patients LOS ANGELES – Among...
AACR Announces Fellows of the AACR Academy Class of 2022
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
Neoadjuvant Treatment with Pembrolizumab Improves Pathologic Complete Response Rates for Patients with Triple-Negative Breast Cancer with Lymph Node Involvement
SAN ANTONIO — The addition of the anti-PD-1 immunotherapeutic pembrolizumab (Keytruda) to neoadjuvant chemotherapy increased the rates of pathologic complete response (pCR)...
Combining Atezolizumab with Neoadjuvant Chemotherapy Does Not Improve Pathologic Complete Response Rates for Patients with Triple-Negative Breast Cancer
SAN ANTONIO — The addition of the anti-PD-L1 immunotherapeutic atezolizumab (Tecentriq) to neoadjuvant chemotherapy for patients with triple-negative breast cancer (TNBC) did...
AACR Announces Fellows of the AACR Academy Class of 2025 and New AACR Academy President
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected 2025 class of Fellows of...
AACR Recognizes 2023-2024 Research Grantees
PHILADELPHIA — The American Association for Cancer Research (AACR) today announced its newest class of grant recipients. Since 1993, the AACR...
AACR Announces Fellows of the AACR Academy Class of 2023 and New AACR Academy President
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
Breast-conserving Therapy May be a Treatment Option for Some Patients with Multiple Breast Lesions
SAN ANTONIO – Patients with multiple tumors in the same breast who underwent a lumpectomy followed by radiation therapy...
American Association for Cancer Research Recognizes New 2020-2021 Research Grantees
PHILADELPHIA — The American Association for Cancer Research (AACR) is proud to announce its newest class of grant recipients....
Accelerated Partial Breast Irradiation, Although Close, was Not Equivalent to Whole Breast Irradiation To Control Ipsilateral Breast Tumor Recurrence
“SAN ANTONIO – Data from the NRG (NSABP B-39/RTOG 0413) trial indicated that ipsilateral breast tumor recurrence (IBTR) rates...
Breast Density, Microcalcifications, and Masses May be Heritable Traits
Some mammographic features are associated with increased breast cancer risk PHILADELPHIA – An analysis of a large Swedish cohort...
AACR Announces Recipients of the 2025 AACR June L. Biedler Prize for Cancer Journalism
PHILADELPHIA – The American Association for Cancer Research (AACR) is pleased to announce the recipients of the 2025 AACR...
American Association for Cancer Research Recognizes New 2019-2020 Research Grantees
PHILADELPHIA — The American Association for Cancer Research (AACR) is proud to announce its newest class of grant recipients....
Armando E. Giuliano, MD, Honored With 2025 William L. McGuire Memorial Lecture Award
SAN ANTONIO – Armando E. Giuliano, MD, will receive the William L. McGuire Memorial Lecture Award during the 2025...
Lisa A. Newman, MD, MPH, Recognized With 2020 AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship
PHILADELPHIA — The American Association for Cancer Research (AACR) is recognizing Lisa A. Newman, MD, MPH, with the 2020...
Graham A. Colditz Honored with AACR Distinguished Lectureship on the Science of Cancer Health Disparities
PHILADELPHIA – The American Association for Cancer Research (AACR) has announced Graham A. Colditz, MD, DrPH, MPH, as the...
American Association for Cancer Research Recognizes 2021-2022 Research Grantees
PHILADELPHIA – The American Association for Cancer Research (AACR) is proud to announce its newest class of grant recipients....
HER2-targeted Therapy Trastuzumab Deruxtecan Shows Early Promise in Patients with Non-breast and Non-gastric Cancers
PHILADELPHIA – A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric cancer types,...
Five Eminent Female Cancer Researchers Receive The Victoria’s Secret Global Fund for Women’s Cancers 2022 Meritorious Awards, In Partnership with Pelotonia & AACR
PHILADELPHIA – Victoria’s Secret, Pelotonia, and the American Association for Cancer Research (AACR) today announced the recipients of The...
Olufunmilayo I. Olopade, MD, FAACR, Honored With 2021 William L. McGuire Memorial Lecture Award
SAN ANTONIO – Olufunmilayo I. Olopade, MD, FAACR, will receive the William L. McGuire Memorial Lecture Award at the...
CDK4/6 Inhibitors Effective in Mice Bearing Multiple Human Cancer Types
BOSTON – Cyclin-dependent kinase (CDK) inhibitors, including palbociclib, were effective against patient-derived xenograft (PDX) mouse models of different tumor...
Jack Cuzick, PhD, Honored With 2023 William L. McGuire Memorial Lecture Award
SAN ANTONIO – Jack Cuzick, PhD, will receive the William L. McGuire Memorial Lecture Award at the 2023 San...
Skipping Adjuvant Radiotherapy May Not Impact Risk of Recurrence or Progression in Patients with Low-risk DCIS
MRI and a DCIS gene profile were used to stratify patients for treatment SAN ANTONIO – Patients with low-risk...